OCT 24, 2019 9:59 PM PDT

Converting Wood into Pharmaceutical Compounds

WRITTEN BY: Nouran Amin

Producing toxic byproducts during the making of pharmaceuticals remains a challenge in the drug manufacturing industry. Normally, increased masses of flammable solvents are utilized during the making of structurally complex drug compounds that consist of several steps.

Scientists have reported their research findings in the journal ACS Central Science. These findings explain a new way to develop pharmaceutically relevant compounds in fewer and more efficient steps with no hazardous materials. The method uses renewable woodchips as the starting material with water as the byproduct. The manufacturing process will take advantage of phenolic compounds found in wood preferably known as lignin and gives wood its known strength.

When making paper, lignin is removed from wood preventing the paper from yellowing and increasing the strength. The remaining lignin is often found in large and unwanted amounts—this made researchers curious to repurpose instead of letting the lignin to go to waste.

Other researchers have utilized lignin through depolymerization. However, these strategic efforts have left scientists curious to see what benefits can be retrieved from this compound?

So, they focused on lignin derivatives because they make ideal starting materials and have similar structural complex chemistry to modern drug compounds. The lignin derivatives make ideal starting materials to synthesize potential pharmaceuticals.

The research team focused on a class of drugs called benzazepines that includes the anti-anxiety therapeutic diazepam. The traditional way of making these drugs includes the generation of toxic waste. But, the catalytic method combines solvents with recyclables and eventually converts monomers from lignin into the benzazepine derivatives without any hazardous byproducts.

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
FEB 25, 2021
Drug Discovery & Development
Future COVID-19 Targets Rapidly Identified with Computer Simulations
FEB 25, 2021
Future COVID-19 Targets Rapidly Identified with Computer Simulations
A recent mechanism as detailed in the novel SARS-CoV2 that causes COVID-19 could help scientists find new therapeutics. ...
APR 06, 2021
Infographics
Psychedelic Medicine 101
APR 06, 2021
Psychedelic Medicine 101
As clinical trials for psychedelics progress, interest in psychedelics is increasing among pharmaceutical firms, clinici ...
APR 02, 2021
Technology
Protein Modeling of SARS-CoV-2 Provides Targets for Vaccine Development
APR 02, 2021
Protein Modeling of SARS-CoV-2 Provides Targets for Vaccine Development
Recent protein modeling of the SARS-CoV-2 spike protein reveals novel areas for vaccine development. The novel SARS-CoV- ...
APR 14, 2021
Drug Discovery & Development
Anti-Aging Compound Improves Glucose Uptake
APR 14, 2021
Anti-Aging Compound Improves Glucose Uptake
According to new research at Washington University School of Medicine in St. Louis, a substance shown to counteract aspe ...
MAY 06, 2021
Drug Discovery & Development
Tweaked Version of Ketamine Could Solve the Opioid Crisis
MAY 06, 2021
Tweaked Version of Ketamine Could Solve the Opioid Crisis
Medications that manage post-operative pain are some of the main entry points to opioid addiction and overdose in the US ...
JUN 03, 2021
Drug Discovery & Development
Smartphone App More Effective than Traditional Treatment for Osteoarthritis
JUN 03, 2021
Smartphone App More Effective than Traditional Treatment for Osteoarthritis
  Researchers at the University of Nottingham in the UK and Joint Academy have found that a clinical evidence-based ...
Loading Comments...